DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

DEA’s suspension of McKesson Corporation Retraction
January 19, 2017

Please see updated information about the DEA’s suspension of McKesson Corporation and controlled substances Continue reading


News About HIV Testing
January 13, 2017

Click here to read a letter from the State Surgeon General about changes to HIV testing including consent requirements. Continue reading